News
Auxita and MyMeds&Me Announce Strategic Partnership to Deliver Integrated Digital Pharmacovigilance Capabilities
Healthcare providers across Canada will soon be able to capture adverse events in the Auxita platform through integration with MyMeds&Me’s pharmacovigilance SaaS platform, Reportum®.
Auxita solves the administrative burden for providers by digitizing workflows and providing interoperability with patient support...
Clinical Trials
OSE Immunotherapeutics Receives Authorization for Phase 1 Clinical Trial of its Multi-Target Multi-Variant COVID-19 Vaccine
OSE Immunotherapeutics announced that the Belgian Federal Agency for Medicines and Health Products (Agence Fédérale des Médicaments et des Produits de Santé - AFMPS) and the Belgian Ethics Committee approved the Phase 1 trial evaluating its COVID-19 vaccine, named...
Clinical Trials
Pfizer-BioNTech Announce Positive Topline Results of Pivotal COVID-19 Vaccine Study in Adolescents
Pfizer Inc. and BioNTech SE announced that, in a Phase 3 trial in adolescents 12 to 15 years of age with or without prior evidence of SARS-CoV-2 infection, the Pfizer-BioNTech COVID-19 vaccine BNT162b2 demonstrated 100% efficacy and robust antibody...
News
Roche launches Elecsys Epstein-Barr Virus (EBV) immunoassay panel to improve EBV infection staging
Roche announced that the Elecsys® EBV panel has launched in countries accepting the CE Mark. Roche will file for approval with the FDA in the future. The Elecsys® EBV panel consists of three immunoassays: Elecsys EBV IgM, Elecsys EBV...
News
CoolMed launch the CoolMed Portable Vaccine Carrier to help with the Covid vaccination roll-out
CoolMed, specialists in medical refrigeration, have strengthened their product offering with the launch of theCoolMed Portable Vaccine Carrier.
The carrier is designed to enable healthcare professionals to easily transport vaccines, solving the problem of cold chain compliance on the move...
Clinical Trials
Daiichi Sankyo begins phase 1 trial in Japan for nafamostat inhalation formulation to treat Covid-19
Daiichi Sankyo Company, Limited announced that it has initiated in Japan a first-in-human phase 1 trial for nafamostat inhalation formulation (DS-2319), which is being developed as a potential medicine for the treatment of the novel coronavirus infectious disease (hereinafter,...
News
Cold Chain Technologies Partners with B Medical Systems
Cold Chain Technologies announced that it is partnering with B Medical Systems, a Luxembourg-based manufacturer and global distributor of medical refrigeration and durable vaccine cold-chain technology. The partnership expands Cold Chain Technologies' portfolio to include hand-carry transport solutions as...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read